Synopsis- Zydus announced today that it has received permission to initiate the Phase II (a) clinical study of its NLRP3 inhibitor “ZYIL1”…
Tag:
Companies
-
-
Active Pharmaceutical Ingredients (API)Metformin
DawaaDost announces one day’s Diabetes Course of ‘Metformin 1000 mg’ at only rupee one per day.
by adminby adminKEYPOINTS: In this programme, DawaaDost will retail Metformin 1000 mg tablets from the top 10 pharmaceutical companies in the country. One in…
-
CabotegravirRilpivirine
European Commission Grants Decision for Vocabria (Cabotegravir) and Rekambys (Rilpivirine) injections to be initiated with or without an oral lead-in period for the long-acting treatment of HIV
by adminby adminSUMMARY: ViiV Healthcare announces the European Commission Decision for Vocabria (Cabotegravir) and Rekambys (Rilpivirine) injections to be initiated with or without an…
-
Agrochemicals
FDA, NIH, and 15 Private Organizations have partnered to Increase Effective Gene Therapies for Rare Diseases.
by adminby adminSUMMARY: The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered to…
-
Launch
Artificial Intelligence/ Computational Biology Innovation Lab Launched by the Mega Companies AstraZeneca, Merck, Pfizer, Teva, AWS, IBF
by adminby adminKey Points – AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges,…